BiopharmIQ by Amp

?? ?? ?????? ???????????????? ?????????????????? ???????????? ???????? ?????????????? See below and the figure for details on PDUFAs still scheduled to readout this quarter. We found these using our free PDUFA calendar on biopharmIQ: https://lnkd.in/g5M8CxHD PDUFA and clinical trial readouts are part of our powerful, affordable online platform that helps sales/marketing/biz dev pros more efficiently and effectively find and target bio/pharma customers, for a fraction of the cost of our competitors. ??? Pending PDUFAs Scheduled for This Quarter: ???????????????? - ?????????????????????????????????? ??Chronic Kidney Disease ???????????????? - ?????????????? ?????????????????????????????? ??Transthyretin Amyloidosis with Cardiomyopathy ?????????????????????? (???? ??????????????????????) - ?????????????????????????????????? ??HIV-Associated Excess Abdominal Fat ?????????????????????? - ?????? ??Uncomplicated Urinary Tract Infection ???????? - ???????????? ???????????????????????? ??Prader-Willi syndrome ?????????????????? - ?????????????????? ?????????????????????????????? ??Paroxysmal Supraventricular Tachycardia ?????????????????? - ???????????? & ?????????????? ?????????????????????????????? ??Hemophilia A or B Check out the table below ???? and our free blog post for details about each of these: https://lnkd.in/gFSC_muH ? Have questions or want to schedule an online demo of our high quality, affordably priced platform with bio/pharma corporate and clinical trials info? Contact [email protected]

?? ????????’?? ??????/???????????? ?????????????? ???????????????? Our BiopharmIQ team identified 651 funding events over $1M in 2024. Key highlights from this year’s report: ?? ???????????? ???????????????(#FundingEvents) – US (361), UK (55), China (46), Switzerland (34) ?? ??.??. ???????????? Tier 1: California (133) and Massachusetts (92) Tier 2: New York (24); Washington (15) Tier 3: Texas (8) Pennsylvania (8) New Jersey (8) Tier 4: 11 states (3-6 Funding Events) Tier 5: 15 states + D.C. (1-2 Funding Events) ?? ???????? ???????????? ???????????? ?????? >$???? ??????????:? ? Seed: 188 funding events;? ? Series A: 218 funding events;? ? Series B: 137 funding events ?? ?????????????? ????????: ? Therapeutics Focus – 412 of 625 companies ???? ?????? ?????? ???????? ???????????? ???? ?????????? ???? ?????????? ???????? ???? ??????/???????????? ??????????????? Read more ?? https://lnkd.in/gfAmCzyW

????????’?? ?????? & ???????????????? ???????????????? ?????????????????? The biopharma industry has faced turbulence and challenges in recent years, yet innovation in biologics continues to surge. We spotlight the ?????? ?????? ???????????????? ???????????????? ?????????????????? ???? ????????, these new companies continue to span many technology areas, with a strong focus on antibody-based therapies: ? Antibody-Based Therapeutics – 16 companies (6 Antibody-Drug Conjugates, 5 Bispecific Antibodies, 7 Other Antibody Therapies) ? Gene Therapy – 9 companies ? Cell Therapy – 7 companies ? RNA-Based Therapeutics – 6 companies ? Peptide & Protein Therapeutics – 8 companies ? Undisclosed/Stealth Mode – 2 companies Antibody-based strategies lead the way, continuing the shift toward precision-targeted biologics with growing emphasis on #ADCs and bispecifics, particularly in oncology and immunotherapy. Meanwhile, gene and cell therapies continue to expand, despite regulatory and scalability challenges. The rise of RNA-based, peptide, and protein therapeutics reflects the industry's focus on specificity and adaptability. The #biologics sector is evolving rapidly, learning from prior #clinical successes and failures. It will be interesting to monitor the success of the new & emerging biologic companies of 2024. Read more ?? https://lnkd.in/gvZGj2_c #Biologics #Biopharmaceuticals #PharmaTrends #LifeSciences #Biotechnology #PharmaIndustry

?? ???????????????? ??????????/???????? ?????????? ???????????? ??????/???????????? ?????????????????? We analyzed early & late stage bio/pharma funding data from our online biopharmIQ platform for December 2024, focusing on geographic distribution. We detected 54 bio/pharma funding events in December 2024 that exceeded $1M. See our blog post for details: https://lnkd.in/gXkS6Vfe Early-stage* leading states were:? ? California (4 companies) ? Massachusetts (3 companies) Late-Stage** leading states: ? California (6 companies) ? New York (3 companies) Looking forward to reporting our annual report! ?? Have questions or want to schedule an online demo?? Contact [email protected]. *Early stage = Angel/Pre-Seed, Seed, Series A funding **Late stage = Series B, C, D, E and Debt financing

?? 2024 Breakthrough: 9 New Cell and Gene Therapies Approvals We found these using our free PDUFA calendar on biopharmIQ: https://lnkd.in/g5M8CxHD 2024 was a remarkable year for cell and gene therapies (CGT) with the FDA approving nine innovative products. Here’s the list with the company and their indications. ?????????????? (?????????????????? ??????????????) ? Steroid-refractory acute graft versus host disease (SR-aGvHD) ?????????????? (????????????????) ? Vascular conduit ???????????????????? (????????????????) ? Hematopoietic progenitor cell transplantation ???????????????? (?????? ????????????????????????) ? Aromatic 13 L-amino acid decarboxylase (AADC) deficiency ???????????????? (?????????????? ????????????????????????) ? Acute lymphoblastic leukemia (ALL) ?????????????? (??????????????????????) ? Synovial sarcoma ???????????? (????????????) ? Hemophilia B ???????????????? (?????????????? ????????????????????????) ? Metachromatic leukodystrophy (MLD) ?????????????? (?????????????? ??????????????????????????????) ? Melanoma What do you think was the most exciting approval in the cell and gene therapies space in 2024? Check out the image below ???? and our free blog post for details about each of these: https://lnkd.in/ggRhYaCy ? Have questions or want to schedule an online demo? Contact [email protected]

?? 94 New/Newly Emerged Bio/Pharma Companies in 2024 We published our biopharmIQ annual report on new/emerging bio/pharma companies. We found 94 new/emerging biopharma companies* in 2024 with 72 headquartered in the U.S. (see graphic ??) 22 California 22 Massachusetts? 7 New York 5 Washington 4 Pennsylvania We were surprised that ~2x as many of the new/emerging bio/pharma companies focus on biologics vs. small molecules. ?? For more details, Check out our free 2024 new/emerging bio/pharma company annual report:?https://lnkd.in/gCMYQYvu ? Have questions or want to schedule an online demo? Contact [email protected]. *Companies with at least $500K in funding and/or that launched with a significant public announcement.

?? 4 biopharma companies FDA PDUFA dates by the end of January We found these using our free PDUFA calendar on biopharmIQ: https://lnkd.in/g5M8CxHD Check out the table below ???? and our free blog post for details about each of these: https://lnkd.in/gdEJs88N PDUFA and clin trial readouts are part of our powerful, affordable online platform: https://lnkd.in/g5M8CxHD ? Have questions or want to schedule an online demo? Contact [email protected]

?? 2 New/Newly Emerged Bio/Pharma Companies in Dec 2024 See text below & table for details on the 2 bio/pharma companies that emerged last month. ?? Check out our free tools page, to set up an alert the next time we identify a new/emerging company: https://lnkd.in/gMkg-W9b ?????????? ???????????????????????? Focus: Small molecule inhibitors using mass spectrometry-based proteomics Location: Boston, Massachusetts, United States ?????????????? ?????? Focus: Epigenetic editing therapy and non-viral programmable delivery? Location: Boston & Cambridge, Massachusetts, United States For more details re: new/emerging biotech companies in Dec 2024, see our blog post on our biopharmIQ web page. ? Have questions or want to schedule an online demo? Contact [email protected].

?? ???????????????? ??????????/???????? ?????????? ???????????? ?????????????? ?????????????????? We analyzed biotech funding data for November 2024.? See our blog post for details: https://lnkd.in/gFCY73Xf Early-stage* leading states were:? ? California (4 companies) ? Texas (2 companies) Late-Stage** leading states: ? California (5 companies) ? Massachusetts (3 companies) Shortly we will analyze data for our 2024 annual report! Funding data provided by our biopharmIQ database/platform ?? Have questions or want to schedule an online demo?? Contact [email protected]. *Early stage = Angel/Pre-Seed, Seed, Series A funding **Late stage = Series B, C, D, E and debt financing

?? 7 New/Newly Emerged Bio/Pharma Companies in Nov 2024 See text below & table for details on these 7 new/emerging companies we identified last month ?? ?? Get notified the next time our team identifies a new/emerging cell therapy company: https://lnkd.in/gSBKbrgj ?????????? ???????????????????????? Focus: Peptide Therapies using AI and Computational Biology Location: San Diego, California, United States ???????????????? ?????? Focus: Scientific Services using AI Location: Tel Aviv, Israel ??????2?????????? ???????????????????????? Focus: Peptide Therapies for obesity Location: Potomac, Maryland, United States ?????????? ???????????????????????? Focus: Antisense Oligonucleotides Location: South San Francisco, California, United States ???????????????? Focus: Adeno-Associated Viral Vector (AAV), Immuno-Oncology Location: Edinburgh, United Kingdom ???????????? ???????????????????????? Focus: Antibody-lectin chimera therapeutics Location: San Diego, California, United States ?????????????????? ???????????? Focus: Pediatric Care Management (Healthcare) Location: Chicago, Illinois, United States For more details re: new/emerging biotech companies in Nov 2024, see our blog post on our biopharmIQ web page. ? Have questions or want to schedule an online demo? Contact [email protected].